FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Frederick de Serres

Research Profile

Living Beings

Chemicals & Drugs

Physiology

Procedures

Genes & Molecular Sequences

Disorders

Concepts & Ideas

Co-author Network

Publications

TOP 3
Ignacio Blanco; Nana Béritze; Mario Argüelles; Victoriano Cárcaba; Fernando Fernández; Sabina Janciauskiene; Katerina Oikonomopoulou; Frederick de Serres; Enrique Fernández-Bustillo; Morley D Hollenberg
Abnormal overexpression of mastocytes in skin biopsies of fibromyalgia patients.
Frederick de Serres; Ignacio Blanco; Enrique Fernández-Bustillo
Ethnic differences in alpha-1 antitrypsin deficiency in the United States of America.
Frederick de Serres; Ignacio Blanco; Enrique Fernández-Bustillo
Estimates of PI*S and PI*Z Alpha-1 antitrypsin deficiency alleles prevalence in the Caribbean and North, Central and South America.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Frederick de Serres (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: Ignacio Blanco; Nana Béritze; Mario Argüelles; Victoriano Cárcaba; Fernando Fernández; Sabina Janciauskiene; Katerina Oikonomopoulou; Frederick de Serres; Enrique Fernández-Bustillo; Morley D Hollenberg
Abnormal overexpression of mastocytes in skin biopsies of fibromyalgia patients.
Clinical rheumatology 2010;29(12):1403-12.
2010: Frederick de Serres; Ignacio Blanco; Enrique Fernández-Bustillo
Ethnic differences in alpha-1 antitrypsin deficiency in the United States of America.
Therapeutic advances in respiratory disease 2010;4(2):63-70.
2009: Frederick de Serres; Ignacio Blanco; Enrique Fernández-Bustillo
Estimates of PI*S and PI*Z Alpha-1 antitrypsin deficiency alleles prevalence in the Caribbean and North, Central and South America.
Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace / Fondazione clinica del lavoro, IRCCS [and] Istituto di clinica tisiologica e malattie apparato respiratorio, Università di Napoli, Secondo ateneo 2009;71(3):96-105.
2008: I Blanco; H Canto; J Flóres; C Camblor; V Cárcaba; Frederick de Serres; S Janciauskiene; E F Bustillo
Long-term augmentation therapy with alpha-1 antitrypsin in an MZ-AAT severe persistent asthma.
Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace / Fondazione clinica del lavoro, IRCCS [and] Istituto di clinica tisiologica e malattie apparato respiratorio, Università di Napoli, Secondo ateneo 2008;69(4):178-82.
2007: Frederick de Serres; Ignacio Blanco; Enrique Fernández-Bustillo
PI S and PI Z alpha-1 antitrypsin deficiency worldwide. A review of existing genetic epidemiological data.
Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace / Fondazione clinica del lavoro, IRCCS [and] Istituto di clinica tisiologica e malattie apparato respiratorio, Università di Napoli, Secondo ateneo 2007;67(4):184-208.
2007: Saeid Ghavami; Mohammad Hashemi; Frederick de Serres; Saeed Naghibzadeh Bajestani; Hamid Mehrabifar; Andrea Leonardi
Trypsin inhibitory capacity in vernal keratoconjunctivitis.
Investigative ophthalmology & visual science 2007;48(1):264-9.
2006: Frederick de Serres; Ignacio Blanco; Enrique Fernández-Bustillo
Estimated numbers and prevalence of PI*S and PI*Z deficiency alleles of alpha1-antitrypsin deficiency in Asia.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 2006;28(6):1091-9.
2006: Frederick de Serres; Ignacio Blanco; Enrique Fernández-Bustillo
Estimating the risk for alpha-1 antitrypsin deficiency among COPD patients: evidence supporting targeted screening.
COPD 2006;3(3):133-9.
2006: Ignacio Blanco; Frederick de Serres; Enrique Fernandez-Bustillo; B Lara; Marc Miravitlles
Estimated numbers and prevalence of PI*S and PI*Z alleles of alpha1-antitrypsin deficiency in European countries.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 2006;27(1):77-84.
2005: Mohammad Hashemi; Seyed Moayed Alavian; Saeid Ghavami; Frederick de Serres; Masoud Salehi; Taher Doroudi; Amir Hossain Mahagheghi Fard; Hamid Mehrabifar; Behzad Milani; Seyed Javad Saeidi Shahri
High prevalence of alpha 1 antitrypsin phenotypes in viral hepatitis B infected patients in Iran.
Hepatology research : the official journal of the Japan Society of Hepatology 2005;33(4):292-7.
2005: Frederick de Serres; Maurizio Luisetti; Ilaria Ferrarotti; Ignacio Blanco; Enrique Fernández-Bustillo
Alpha-1 antitrypsin deficiency in Italy: regional differences of the PIS and PIZ deficiency alleles.
Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace / Fondazione clinica del lavoro, IRCCS [and] Istituto di clinica tisiologica e malattie apparato respiratorio, Università di Napoli, Secondo ateneo 2005;63(3):133-41.
2005: Saeid Ghavami; Mohammad Hashemi; Hossain Ali Shahriari; Saeed Naghibzadeh Bajestani; Frederick de Serres; Ebrahim Miri Moghaddam; Morteza Kazemi; Seyed Moayed Alavian; Mohsen Taheri; Ignacio Blanco; Enrique Fernandez-Bustillo
Alpha-1-antitrypsin phenotypes and HLA-B27 typing in uveitis patients in southeast Iran.
Clinical biochemistry 2005;38(5):425-32.
2005: Frederick de Serres; Ignacio Blanco; Enrique Fernández-Bustillo
Health implications of alpha1-antitrypsin deficiency in Sub-Sahara African countries and their emigrants in Europe and the New World.
Genetics in medicine : official journal of the American College of Medical Genetics 2005;7(3):175-84.
2005: Lgnacio Eduardo Blanco; Frederick de Serres; Enrique Fernańdez-Bustillo; Daniel Al Kassam; Daniel Arbesú; Carmen Rodríguez; Juan Carlos Torre
alpha1-Antitrypsin and fibromyalgia: new data in favour of the inflammatory hypothesis of fibromyalgia.
Medical hypotheses 2005;64(4):759-69.
2004: Ignacio Blanco; Enrique Fernández-Bustillo; Frederick de Serres; Daniel Alkassam; Carmen Rodríguez Menéndez
[PI*S and PI*Z alpha 1-antitrypsin deficiency: estimated prevalence and number of deficient subjects in Spain].
Medicina clínica 2004;123(20):761-5.
2004: Ignacio Blanco; Hortensia Canto; Frederick de Serres; Enrique Fernandez-Bustillo; Maria Carmen Rodríguez
Alpha1-antitrypsin replacement therapy controls fibromyalgia symptoms in 2 patients with PI ZZ alpha1-antitrypsin deficiency.
The Journal of rheumatology 2004;31(10):2082-5.
2003: Frederick de Serres
Alpha-1 antitrypsin deficiency is not a rare disease but a disease that is rarely diagnosed.
Environmental health perspectives 2003;111(16):1851-4.
2003: Frederick de Serres; Ignacio Blanco; Enrique Fernández-Bustillo
Genetic epidemiology of alpha-1 antitrypsin deficiency in North America and Australia/New Zealand: Australia, Canada, New Zealand and the United States of America.
Clinical genetics 2003;64(5):382-97.
2003: Richard R Sharp; Frederick de Serres; Lee Newman; Robert A Sandhaus; John W Walsh; Ernie Hood; G Jean Harry
Environmental, occupational, and genetic risk factors for alpha-1 antitrypsin deficiency.
Environmental health perspectives 2003;111(14):1749-52.
2003: Frederick de Serres; Ignacio Blanco; Enrique Fernández-Bustillo
Genetic epidemiology of alpha-1 antitrypsin deficiency in southern Europe: France, Italy, Portugal and Spain.
Clinical genetics 2003;63(6):490-509.
2002: Frederick de Serres
Worldwide racial and ethnic distribution of alpha1-antitrypsin deficiency: summary of an analysis of published genetic epidemiologic surveys.
Chest 2002;122(5):1818-29.
1999: N N Khromov-Borisov; Igor Rogozin; J A Pêgas Henriques; Frederick de Serres
Similarity pattern analysis in mutational distributions.
Mutation research 1999;430(1):55-74.
1999: Frederick de Serres; H E Brockman
Comparison of the spectra of genetic damage in formaldehyde-induced ad-3 mutations between DNA repair-proficient and -deficient heterokaryons of Neurospora crassa.
Mutation research 1999;437(2):151-63.
1997: Frederick de Serres; Heinrich V Malling; H E Brockman; T M Ong
Quantitative and qualitative comparison of spontaneous and chemical-induced specific-locus mutation in the ad-3 region of heterokaryon 12 of Neurospora crassa.
Mutation research 1997;375(1):53-72.
1997: Frederick de Serres; B B Webber
Quantitative and qualitative comparisons of spontaneous and radiation-induced specific-locus mutation in the ad-3 region of heterokaryon 12 of Neurospora crassa.
Mutation research 1997;375(1):37-52.
1995: Frederick de Serres; Heinrich V Malling; B B Webber; H E Brockman
Quantitative and qualitative aspects of spontaneous specific-locus mutation in the ad-3 region of heterokaryon 12 of Neurospora crassa.
Mutation research 1995;332(1-2):45-54.
1995: Frederick de Serres; Heinrich V Malling; Tong-man Ong
Comparison of the mutagenicity and mutagen specificity of ethylenimine with triethylenemelamine in the ad-3 region of heterokaryon 12 of Neurospora crassa.
Mutation research 1995;328(2):193-205.
1995: Frederick de Serres; H E Brockman
Ethylene oxide: induction of specific-locus mutations in the ad-3 region of heterokaryon 12 of Neurospora crassa and implications for genetic risk assessment of human exposure in the workplace.
Mutation research 1995;328(1):31-47.
1995: Frederick de Serres; Heinrich V Malling
Triethylenemelamine: induction of specific-locus mutations in the ad-3 region of heterokaryon 12 of Neurospora crassa.
Mutation research 1995;327(1-2):87-111.
1994: S S Sandhu; Frederick de Serres; H N Gopalan; William Grant; D Svendsgaard; J Velemínský; G C Becking
Environmental monitoring for genotoxicity with plant systems. Results and recommendations.
Mutation research 1994;310(2):257-63.
1994: S S Sandhu; Frederick de Serres; H N Gopalan; William Grant; J Velemínský; G C Becking
Environmental monitoring for genotoxicity with plant systems. An introduction and study design.
Mutation research 1994;310(2):169-73.
1994: Frederick de Serres; Heinrich V Malling
Forward-mutation tests on the antitumor agent ICR-170 in Neurospora crassa demonstrate that it induces gene/point mutations in the ad-3 region and an exceptionally high frequency of multiple-locus ad-3 mutations with closely linked sites of recessive lethal damage.
Mutation research 1994;310(1):15-36.
1994: Frederick de Serres
X-ray-induced specific-locus mutations in the ad-3 region of two-component heterokaryons of Neurospora crassa. XII. Analysis of multiple-locus ad-3 mutations reveals a nonrandom distribution of the separate sites of recessive lethal damage throughout the genome.
Mutation research 1994;307(1):175-84.
1994: Frederick de Serres
Genetic risk assessment and specific-locus mutations in the ad-3 region of Neurospora crassa.
Environmental health perspectives 1994;102 Suppl 1():83-90.
1994: Frederick de Serres
Commentary on an unresolved problem: effective genetic risk assessment of human exposure to mutagenic environmental agents.
Environmental and molecular mutagenesis 1994;23 Suppl 24():7-10.
1993: Frederick de Serres; H E Brockman
Comparison of the spectra of genetic damage in N4-hydroxycytidine-induced ad-3 mutations between nucleotide excision repair-proficient and -deficient heterokaryons of Neurospora crassa.
Mutation research 1993;285(2):145-63.
1992: Frederick de Serres; L K Overton; B M Sadler
X-ray-induced specific-locus mutations in the ad-3 region of two-component heterokaryons of Neurospora crassa. XI. Heterozygous effects of gene/point mutations of genotype ad-3A or ad-3B.
Mutation research 1992;269(1):149-69.
1992: Frederick de Serres; L K Overton; B M Sadler
X-ray-induced specific-locus mutations in the ad-3 region of two-component heterokaryons of Neurospora crassa. X. Heterozygous effects of multilocus deletion mutations of genotype ad-3A or ad-3B.
Mutation research 1992;267(1):105-24.
1992: D J Brusick; J Ashby; Frederick de Serres; Paul H M Lohman; T Matsushima; B E Matter; M L Mendelsohn; D H Moore; S Nesnow; Michael D Waters
International Commission for Protection Against Environmental Mutagens and Carcinogens. A method for combining and comparing short-term genotoxicity test data: preface. A report from ICPEMC Committee 1.
Mutation research 1992;266(1):1-6.
1992: Frederick de Serres
Characteristics of spontaneous and induced specific-locus mutation in the ad-3 region of Neurospora crassa: utilization in genetic risk assessment.
Environmental and molecular mutagenesis 1992;20(4):246-59.
1992: Frederick de Serres
Development of a specific-locus assay in the ad-3 region of two-component heterokaryons of Neurospora: a review.
Environmental and molecular mutagenesis 1992;20(4):225-45.
1991: Frederick de Serres; H E Brockman
Qualitative differences in the spectra of genetic damage in 2-aminopurine-induced ad-3 mutants between nucleotide excision-repair-proficient and -deficient strains of Neurospora crassa.
Mutation research 1991;251(1):41-58.
1991: Frederick de Serres
Utilization of the specific-locus assay in the ad-3 region of two-component heterokaryons of Neurospora for risk assessment of environmental chemicals.
Mutation research 1991;250(1-2):251-74.
1991: Frederick de Serres
The genetic toxicology of 2-amino-N6-hydroxyadenine in eukaryotic organisms: significance for genetic risk assessment.
Mutation research 1991;253(1):5-15.
1991: Frederick de Serres; David G Hoel
Objectives of the collaborative study on the genetic toxicology of 2-amino-N6-hydroxyadenine: an exercise in genetic risk assessment.
Mutation research 1991;253(1):1-3.
1991: Frederick de Serres; H E Brockman; L K Overton
2-Amino-N6-hydroxyadenine induces gene/point mutations and multiple-locus mutations, but not multilocus deletion mutations, in the ad-3 region of a two-component heterokaryon of Neurospora crassa.
Mutation research 1991;253(1):21-32.
1991: S S Sandhu; Frederick de Serres; H N Gopalan; William Grant; J Veleminsky; G C Becking
Status report of the International Programme on Chemical Safety's Collaborative Study on plant test systems.
Mutation research 1991;257(1):19-25.
1991: H E Brockman; Frederick de Serres
Mutagenic potency and specificity of procarbazine in the ad-3 forward-mutation test in growing cultures of heterokaryon 12 of Neurospora crassa.
Mutation research 1991;246(1):193-204.
1991: Frederick de Serres
X-ray-induced specific-locus mutations in the ad-3 region of two-component heterokaryons of Neurospora crassa, IX. Mutational spectra as a function of X-ray dose.
Mutation research 1991;246(1):15-30.
1991: Frederick de Serres
X-ray-induced specific-locus mutations in the ad-3 region of two-component heterokaryons of Neurospora crassa. VIII. Dose-dependence of the overall spectrum.
Mutation research 1991;246(1):1-13.
1990: Frederick de Serres
X-ray-induced specific-locus mutations in the ad-3 region of two-component heterokaryons of Neurospora crassa. VII. Genetic lesions resulting in gene/point mutations at the ad-3B locus have different dose-response relationships.
Mutation research 1990;232(2):115-40.
1990: Frederick de Serres
X-ray-induced specific-locus mutations in the ad-3 region of two-component heterokaryons of Neurospora crassa. VI. Induction kinetics of gene/point mutations, multilocus deletions and multiple-locus mutations.
Mutation research 1990;231(2):109-24.
1990: Frederick de Serres
X-ray-induced specific-locus mutations in the ad-3 region of two-component heterokaryons of Neurospora crassa. V. Irreparable mutants of genotype ad-3A ad-3B, ad-3A ad-3B nic-2, and ad-3B nic-2 result from multilocus deletion and an unexpectedly high frequency of multiple-locus mutations.
Mutation research 1990;229(1):49-67.
1990: Frederick de Serres
Heterozygous effects of X-ray-induced specific locus mutations in the ad-3 region of Neurospora crassa: implications for human genetic risk assessment.
Progress in clinical and biological research 1990;340C():139-50.
1989: J S Dubins; L K Overton; R R Cobb; Frederick de Serres
Classical and molecular genetic analyses of his-3 mutants of Neurospora crassa. II. Southern blot analyses and molecular mechanisms of mutagenicity.
Mutation research 1989;215(1):39-47.
1989: Frederick de Serres
X-ray-induced specific-locus mutations in the ad-3 region of two-component heterokaryons of Neurospora crassa. IV. Irreparable mutants of genotype ad-3A and ad-3B result from multilocus deletion and an unexpectedly high frequency of multiple-locus mutations.
Mutation research 1989;214(2):297-319.
1989: L K Overton; J S Dubins; Frederick de Serres
Molecular and classical genetic analyses of his-3 mutants of Neurospora crassa. I. Tests for allelic complementation and specific revertibility.
Mutation research 1989;214(2):267-83.
1989: H E Brockman; Frederick de Serres; C Y Hung; T Ong
Effect of the uvs-2 allele of Neurospora crassa on the mutagenic potency of two N-hydroxylaminopurines and 2-aminopurine in the ad-3 forward-mutation test.
Mutation research 1989;218(1):1-11.
1989: Frederick de Serres
X-ray-induced specific locus mutations in the ad-3 region of two-component heterokaryons of Neurospora crassa. III. Genetic fine structure analysis of the ad-3 and immediately adjacent genetic regions by means of complementation tests.
Mutation research 1989;211(1):89-102.
1989: Frederick de Serres
X-ray-induced specific-locus mutations in the ad-3 region of two-component heterokaryons of Neurospora crassa. II. More extensive genetic tests reveal an unexpectedly high frequency of multiple-locus mutations.
Mutation research 1989;210(2):281-90.
1989: David M DeMarini; H E Brockman; Frederick de Serres; H H Evans; L F Stankowski; AW Hsie
Specific-locus mutations induced in eukaryotes (especially mammalian cells) by radiation and chemicals: a perspective.
Mutation research 1989;220(1):11-29.
1988: Frederick de Serres; I R Miller
X-ray-induced specific locus mutations in the ad-3 region of two-component heterokaryons of Neurospora crassa. I. Modification of the heterozygous effects of multilocus deletions covering the ad-3A or ad-3B loci.
Mutation research 1988;201(1):49-64.
1988: Frederick de Serres
International Commission for Protection against Environmental Mutagens and Carcinogens. ICPEMC topic No. 2. Heterozygous effects of multilocus deletions.
Mutation research 1988;196(1):95-9.
1988: Frederick de Serres; H E Brockman; C Y Hung
Effect of the homokaryotic state of the uvs-2 allele in Neurospora crassa on formaldehyde-induced killing and ad-3 mutation.
Mutation research 1988;199(1):235-42.
1988: Martha M Moore; David M DeMarini; Frederick de Serres; Kenneth Tindall
Mammalian cell mutagenesis, Banbury Conference.
Mutation research 1988;203(1):69-78.
1988: Frederick de Serres
Banbury Center DNA Adducts Workshop. Workshop on DNA Adducts, Banbury Center, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, NY (U.S.A.), Sept. 30-Oct. 2, 1986.
Mutation research 1988;203(1):55-68.
1988: Frederick de Serres
Critical factors in genetic risk assessment of human exposure to environmental chemicals.
Birth defects original article series 1988;24(5):13-24.
1987: C Wilson; Frederick de Serres
Alexander Hollaender 1898-1986.
Mutation research 1987;179(1):1-3.
1987: Frederick de Serres; T Matsushima
Meeting report: Deployment of short-term assays for environmental mutagens and carcinogens.
Mutation research 1987;182(3):173-84.
1987: H E Brockman; Frederick de Serres; Tong-man Ong; C Y Hung
Two N-hydroxylaminopurines are highly mutagenic in the ad-3 forward-mutation test in growing cultures of heterokaryon 12 of Neurospora crassa.
Mutation research 1987;177(1):61-75.
1986: Frederick de Serres
Hycanthone: an unresolved case study in risk assessment.
Mutation research 1986;164(4):199-201.
1986: D Brusick; J Ashby; Frederick de Serres; P Lohman; T Matsushima; B Matter; M Mendelsohn; M Waters
Weight-of-evidence scheme for evaluation and interpretation of short-term results.
Progress in clinical and biological research 1986;209B():121-9.
1986: Frederick de Serres; H E Brockman
Genetic characterization of the mutagenic activity of environmental chemicals at specific loci in two-component heterokaryons of Neurospora crassa.
Progress in clinical and biological research 1986;209A():209-18.
1986: A J Griffiths; H E Brockman; David M DeMarini; Frederick de Serres
The efficacy of Neurospora in detecting agents that cause aneuploidy.
Mutation research 1986;167(1-2):35-45.
1985: H E Brockman; Frederick de Serres; C Y Hung
Effect of the homokaryotic or heterokaryotic state of the uvs-2 allele in Neurospora crassa on mitomycin C-induced killing and ad-3 mutation.
Mutation research 1985;150(1-2):193-202.
1985: W Sheridan; Frederick de Serres
Report of the conference on DNA adducts: dosimeters to monitor human exposure to environmental mutagens and carcinogens.
Mutation research 1985;147(1-2):59-63.
1985: Frederick de Serres
Mechanisms to stimulate research on assay systems to detect aneuploidy.
Basic life sciences 1985;36():507-11.
1985: Frederick de Serres; H E Brockman; C Y Hung; L K Overton
Mutagenicity of 2-aminopurine, 6-N-hydroxylaminopurine, and 2-amino-N6-hydroxyadenine in Neurospora crassa.
Basic life sciences 1985;31():381-9.
1984: Frederick de Serres; T Matsushima
Environmental mutagenesis and carcinogenesis: test method development, validation and utilization.
Mutation research 1984;130(5):353-9.
1984: L B Russell; C S Aaron; Frederick de Serres; Walderico M Generoso; K L Kannan; M Shelby; J Springer; P Voytek
A report of the U.S. Environmental Protection Agency Gene-Tox Program. Evaluation of mutagenicity assays for purposes of genetic risk assessment.
Mutation research 1984;134(2-3):143-57.
1984: H E Brockman; Frederick de Serres; Tong-man Ong; David M DeMarini; A J Katz; A J Griffiths; R S Stafford
Mutation tests in Neurospora crassa. A report of the U.S. Environmental Protection Agency Gene-Tox Program.
Mutation research 1984;133(2):87-134.
1983: Frederick de Serres; H Inoue; M E Schüpbach
Mutagenesis at the ad-3A and ad-3B loci in haploid UV-sensitive strains of Neurospora crassa. VI. Genetic characterization of ad-3 mutants provides evidence for qualitative differences in the spectrum of genetic alterations between wild-type and nucleotide excision-repair-deficient strains.
Mutation research 1983;108(1-3):93-108.
1983: Frederick de Serres; Heinrich V Malling
The role of Neurospora in evaluating environmental chemicals for mutagenic activity.
Annals of the New York Academy of Sciences 1983;407():177-85.
1983: Frederick de Serres
The use of Neurospora in the evaluation of the mutagenic activity of environmental chemicals.
Environmental mutagenesis 1983;5(3):341-51.
1983: A A van Zeeland; G R Mohn; C S Aaron; B W Glickman; M Brendel; Frederick de Serres; C Y Hung; H E Brockman
Molecular dosimetry of the chemical mutagen ethyl methanesulfonate. Quantitative comparison of the mutagenic potency in Neurospora crassa and Saccharomyces cerevisiae.
Mutation research 1983;119(1):45-54.
1982: Frederick de Serres
Comparison of the induction of specific locus mutations in wild-type and repair-deficient strains of Neurospora crassa.
Basic life sciences 1982;20():335-43.
1981: H Inoue; R C Harvey; D F Callen; Frederick de Serres
Mutagenesis at the ad-3A and ad-3B loci in haploid UV-sensitive strains of Neurospora crassa. V. Comparison of dose--response curves of single- and double-mutant strains with wild-type.
Mutation research 1981;84(1):49-71.
1981: M E Schüpbach; Frederick de Serres
Mutagenesis at the ad-3A and ad-3B loci haploid UV-sensitive strains of Neurospora crassa. III. Comparison of dose-response curves for inactivation and mutation induced by gamma-rays.
Mutation research 1981;81(1):49-58.
1981: T Ong; Frederick de Serres
Genetic analysis of ad-3 mutants induced by AF-2 and two other nitrofurans in Neurospora crassa.
Environmental mutagenesis 1981;3(2):151-8.
1981: H Inoue; Tong-man Ong; Frederick de Serres
Mutagenesis at the ad-3A and ad-3B loci in haploid UV-sensitive strains of Neurospora crassa. IV. Comparison of dose-response curves for MNNG, 4NQO and ICR-170 induced inactivation and mutation-induction.
Mutation research 1981;80(1):27-41.
1980: I F Purchase; Frederick de Serres
International programme for the evaluation of short-term tests for carcinogenicity.
Archives of toxicology 1980;46(1-2):195-8.
1980: T Ong; Frederick de Serres
Genetic analysis of adenine-3 mutants induced by hycanthone, lucanthone and their indazole analogs in Neurospora crassa.
Journal of environmental pathology and toxicology 1980;4(5-6):1-8.
1980: Frederick de Serres
Mutagenesis at the ad-3A and ad-3B loci in haploid UV-sensitive strains of Neurospora crassa. II. Comparison of dose-response curves for inactivation and mutation induced by UV.
Mutation research 1980;71(2):181-91.
1980: Frederick de Serres; H Inoue; M E Schüpbach
Mutagenesis at the ad-3A and ad-3B loci in haploid UV-sensitive strains of Neurospora crassa. I. Development of isogenic strains and spontaneous mutability.
Mutation research 1980;71(1):53-65.
1980: J W Drake; Frederick de Serres; W J Darby; V C Dunkel; D G Longfellow; H Ott; I F Purchase; C Ramel; C Schlatter; E M Smith
Rationale for deployment of short-term assays for evidence of carcinogenicity.
IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans. Supplement 1980;(2 Suppl):295-308.
1980: Frederick de Serres
Mutation-induction in repair-deficient strains of Neurospora.
Basic life sciences 1980;15():75-84.
1980: N Loprieno; R C von Borstel; L Herrera; Frederick de Serres
Mutagenesis assays with yeasts and moulds.
IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans. Supplement 1980;(2 Suppl):135-55.
1979: Frederick de Serres
Aneuploidy as a human health problem of significance in environmental mutagenesis.
Environmental health perspectives 1979;31():1-2.
1979: L A Poirier; Frederick de Serres
Initial National Cancer Institute studies on mutagenesis as a prescreen for chemical carcinogens: an appraisal.
Journal of the National Cancer Institute 1979;62(4):919-26.
1979: T Ong; B Slade; Frederick de Serres
Mutagenicity and mutagenic specificity of metronidazole and niridazole in Neurospora crassa.
Journal of environmental pathology and toxicology 1979;2(4):1109-18.
1979: Frederick de Serres; M D Shelby
The Salmonella mutagenicity assay: recommendations.
Science (New York, N.Y.) 1979;203(4380):563-5.
1979: Frederick de Serres
Problems associated with the application of short-term tests for mutagenicity in mass-screening programs.
Environmental mutagenesis 1979;1(3):203-8.
1978: L A Schairer; J Van't Hof; C G Hayes; R M Burton; Frederick de Serres
Exploratory monitoring of air pollutants for mutagenicity activity with the Tradescantia stamen hair system.
Environmental health perspectives 1978;27():51-60.
1978: Frederick de Serres
Introduction: utilization of higher plant systems as monitors of environmental mutagens.
Environmental health perspectives 1978;27():3-6.
1978: Frederick de Serres
Report of the conference on modification of mutagenic and carcinogenic activity. Williamsburg, Virginia, October 24--26, 1977.
Mutation research 1978;54(2):197-202.
1978: Frederick de Serres
[Effective use of rapid tests to evaluate the mutagenicity of environmental chemicals].
Genetika 1978;14(6):935-46.
1977: Frederick de Serres
Strength and weaknesses of microbial test results for predicting human response.
Journal of environmental pathology and toxicology 1977;1(2):43-8.
1976: Frederick de Serres
Perspective in a period of transition.
Mutation research 1976;38(6):355-7.
1976: Frederick de Serres
Mutagenicity of chemical carcinogens.
Mutation research 1976;41(1 spel. no):43-50.
1976: Frederick de Serres
Prospects for a revolution in the methods of toxicological evaluation.
Mutation research 1976;38(3):165-76.
1976: Frederick de Serres
The utility of short-term tests for mutagenicity.
Mutation research 1976;38(1):1-2.
1976: Frederick de Serres
Letter: Mutagenicity of commercially available hair dyes. What significance for humans?
Journal of toxicology and environmental health 1976;1(3):539-41.
1975: C R Fisher; H V Malling; Frederick de Serres; S Snyder
Mutagenicity of actinomycin D in Neurospora crassa.
Mutation research 1975;33(2-3):187-92.